PHYLLIS HENDERSON: Open Payments
NPI 1487863999 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$97 in 5 payments from 5 companies in 2025. Trend: 2023 $304 · 2024 $83 · 2025 $97
Food & beverage: $97
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Auvelity, INVEGA SUSTENNA, INGREZZA, ARISTADA, CAPLYTA.
Industry payments across WA — which companies pay providers there.
